Simplex Trading
LXRX icon

Simplex Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Simplex Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Buy
132,200
+47,300
+56% +$68.8K ﹤0.01% 4263
2025
Q4 		$97.6K Sell
84,900
-48,500
-36% -$66.6K ﹤0.01% 5028
2025
Q3 		$180K Sell
133,400
-120,700
-48% -$137K ﹤0.01% 5067
2025
Q2 		$240K Buy
254,100
+2,500
+1% +$1.62K ﹤0.01% 4317
2025
Q1 		$115K Buy
251,600
+131,300
+109% +$82.8K ﹤0.01% 4915
2024
Q4 		$88K Sell
120,300
-47,900
-28% -$57.7K ﹤0.01% 5293
2024
Q3 		$264K Buy
168,200
+73,800
+78% +$131K ﹤0.01% 4258
2024
Q2 		$158K Sell
94,400
-17,500
-16% -$31.4K ﹤0.01% 4884
2024
Q1 		$268K Buy
111,900
+101,900
+1,019% +$219K ﹤0.01% 4537
2023
Q4 		$15K Sell
10,000
-21,400
-68% -$25.4K ﹤0.01% 7141
2023
Q3 		$34K Sell
31,400
-7,800
-20% -$13.7K ﹤0.01% 6150
2023
Q2 		$89K Buy
39,200
+23,400
+148% +$62.1K ﹤0.01% 5226
2023
Q1 		$38K Buy
15,800
+3,300
+26% +$7.56K ﹤0.01% 6234
2022
Q4 		$23K Sell
12,500
-16,200
-56% -$34.5K ﹤0.01% 6737
2022
Q3 		$68K Buy
28,700
+18,500
+181% +$51.2K ﹤0.01% 6024
2022
Q2 		$18K Sell
10,200
-10,400
-50% -$19.8K ﹤0.01% 7723
2022
Q1 		$43K Buy
20,600
+14,500
+238% +$40.2K ﹤0.01% 7343
2021
Q4 		$24K Sell
6,100
-57,400
-90% -$279K ﹤0.01% 8153
2021
Q3 		$276K Buy
63,500
+50,300
+381% +$206K ﹤0.01% 5057
2021
Q2 		$60K Buy
+13,200
New +$63.6K ﹤0.01% 7428
2021
Q1 		– Sell
-922
Closed -$315K – 9482
2020
Q4 		$315K Buy
922
+771
+511% +$1.47K ﹤0.01% 4004
2020
Q3 		$21K Buy
151
+43
+40% +$77 ﹤0.01% 6335
2020
Q2 		$21K Sell
108
-9
-8% -$18 ﹤0.01% 6182
2020
Q1 		$22K Sell
117
-199
-63% -$592 ﹤0.01% 5873
2019
Q4 		$131K Sell
316
-260
-45% -$1K ﹤0.01% 4218
2019
Q3 		$173K Buy
576
+573
+19,100% +$1.77K ﹤0.01% 3714
2019
Q2 		$1K Sell
3
-169
-98% -$1.01K ﹤0.01% 6878
2019
Q1 		$95K Buy
172
+95
+123% +$577 ﹤0.01% 4379
2018
Q4 		$51K Sell
77
-256
-77% -$2.07K ﹤0.01% 4502
2018
Q3 		$355K Buy
333
+178
+115% +$2.04K ﹤0.01% 2975
2018
Q2 		$186K Buy
+155
New +$1.58K ﹤0.01% 3578
2018
Q1 		– Sell
-65
Closed -$1K – 6544
2017
Q4 		$1K Sell
65
-476
-88% -$4.95K ﹤0.01% 5559
2017
Q3 		$23K Buy
541
+196
+57% +$2.89K ﹤0.01% 3026
2017
Q2 		$60K Sell
345
-127
-27% -$1.97K ﹤0.01% 2223
2017
Q1 		$16K Buy
472
+367
+350% +$5.45K ﹤0.01% 3488
2016
Q4 		$5K Buy
105
+42
+67% +$674 ﹤0.01% 4358
2016
Q3 		$16K Buy
63
+50
+385% +$805 ﹤0.01% 3195
2016
Q2 		$2K Buy
+13
New +$176 ﹤0.01% 4952

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Simplex Trading's LXRX Position: Q1 2026 in Review

Simplex Trading sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 14,758 shares — an estimated $21.5K sold.

Simplex Trading first reported a position in LXRX in Q3 2015 and held it in 33 quarters. The position peaked at $535K in Q4 2020. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Simplex Trading reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 14,758 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $21.5K.
  • Simplex Trading first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 33 quarters.
  • Simplex Trading's Lexicon Pharmaceuticals position peaked at $535K in Q4 2020.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.